Trovagene Inc. (TROV)

Trade TROV now with
11/14/2019 8:08:40 AM Trovagene Presents Positive Data In Metastatic Prostate Cancer Phase 2 Trial S
11/6/2019 9:13:42 AM Trovagene Announces Data From Acute Myeloid Leukemia Phase 1b/2 Trial Of Onvansertib Chosen For Oral Presentation
10/22/2019 8:17:11 AM Trovagene Announces Positive Response To Treatment In Phase 1b/2 Trial Of Onvansertib
9/30/2019 8:26:20 AM Trovagene Presents Results From Phase 1b/2 Study Of Onvansertib In Patients With Relapsed/refractory AML
9/19/2019 8:16:36 AM Trovagene Reports Completion Of Phase 1b Trial Of Onvansertib In Acute Myeloid Leukemia
8/26/2019 8:08:31 AM Trovagene Presents Positive Clinical Data From Ongoing Phase 2 Study Of Onvansertib In MCRPC
7/9/2019 8:05:16 AM Trovagene Announces Initiation Of Enrollment For Phase 1b/2 Clinical Trial In KRAS-Mutated Colorectal Cancer
5/23/2019 8:13:39 AM Trovagene And Nektar Enter Research Collaboration To Explore Combination Of Onvansertib And ONZEALD
5/7/2019 4:21:59 PM Trovagene Q1 Loss/share $1.02 Vs. Loss $6.23 Year Ago
4/23/2019 8:09:16 AM Trovagene Announces Data Demonstrating Significant Synergy Of Onvansertib In Combination With Venetoclax
4/5/2019 8:19:25 AM Trovagene Announces Update To Phase 1b/2 AML Trial Data Presented